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Abstract

The role of Tbx2 in germ layer suppression and dorsoventral
patterning during early vertebrate development
By: Shoshana Reich
Advisor: Dr. Daniel Weinstein

The differentiation of the three primary germ layers is precisely regulated by inductive cues, the
intracellular networks through which these signals are transduced, and a broad array of nuclear
proteins, such as transcription factors and epigenetic modifiers. Precise regulation of these various
factors is crucial to proper development. Members of the T-box family of DNA-binding proteins
play a prominent role in the differentiation of the three primary germ layers. VegT, Brachyury,
and Eomesodermin function as transcriptional activators, are expressed in the presumptive
mesendoderm and, in addition to directly activating the transcription of endoderm- and mesodermspecific genes, serve variously as regulators of growth factor signaling during induction of these
germ layers. In contrast, expression of the T-box gene tbx2 is present in the embryonic ectoderm,
where Tbx2 functions as a transcriptional repressor and inhibits mesodermal and endodermal
differentiation by the TGFβ ligand Activin. Notably, Tbx2 misexpression also promotes dorsal
ectodermal fate via inhibition of the BMP branch of the TGFβ signaling network. We report here
that Tbx2 physically associates with both Smad1 and Smad2, mediators of BMP and
Activin/Nodal signaling, respectively. We perform structure function analysis of Tbx2 to elucidate
the roles of both Tbx2-Smad interaction and Tbx2-DNA binding in germ layer suppression. Our
studies demonstrate that Tbx2 associates with intracellular mediators of the Activin/Nodal and
BMP/GDF pathways, crucial factors in germ layer patterning and differentiation. We have
identified a novel repressor domain within Tbx2, and have determined that Tbx2 DNA-binding
activity is required for repression of TGFβ signaling. Protein- protein interaction assays suggest
that Tbx2-mediated repression involves an epigenetic mechanism. Finally, our data also point to
overlapping yet distinct mechanisms for Tbx2-mediated repression of Activin/Nodal and
BMP/GDF signaling.
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1 Chapter I: General introduction
1.1 Introduction
Understanding the development of an embryo from a single totipotent cell to a highly
differentiated, multicellular organism is a foundational concern of developmental biology. In
triploblasts, three embryonic germ layers, ectoderm, mesoderm, and endoderm, give rise to
virtually all tissue types. The endodermal germ layer differentiates into pancreas, liver, lung, and
other components of the digestive and respiratory systems. The mesodermal layer gives rise the
muscular, circulatory, and skeletal systems, and the epidermis, neural tissue, neural crest, and
cranial sensory placodes derive from ectoderm. The precise coordination of germ layer
differentiation is, by definition, crucial for normal embryogenesis. In order to study development
in vivo, I use the model organism Xenopus laevis.

1.2 X. laevis as a model organism
X. laevis is an excellent model for studying early development because their embryos are large,
easy to visualize, and well suited for micro-dissections and microinjection of exogenous
biomaterials. During X. laevis development, the formation and patterning of the three embryonic
germ layers is a rapid and tightly regulated process. The germ layers in a developing embryo give
rise to almost all tissue types; therefore, precise coordination of signaling networks that regulate
differentiation of these germ layers is crucial. How an embryo develops from a single totipotent
cell to a highly differentiated, multicellular organism is a subject of intense scrutiny. Several key
biological processes that occur in cells during early stages of development in vivo are, in several
respects, similar to the mechanisms by which embryonic cells can be maintained in a stem-like
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state in vitro. In fact, many transcription factors that are responsible for controlling cell fate
commitment in developing embryos also regulate development of pluripotent stem cells
(Takahashi and Yamanaka, 2006). Therefore, identifying transcription factors necessary for germ
layer differentiation has far-reaching implications for the fields of both developmental biology and
regenerative medicine.

X. laevis is used extensively to study development. Fertilization and development in X. laevis is
external, and can therefore be easily visualized and studied. Following fertilization, rapid mitotic
divisions result in a solid ball of cells called a morula. Subsequent cell divisions give rise to a
blastula, a mass of cells surrounding a fluid-filled cavity called the blastocoel. During these
developmental stages, the embryo contains maternally-supplied proteins and transcripts; little to
no zygotic transcription occurs (Skirkanich et al., 2011). Once a specific nuclear to cytoplasmic
volume ratio is reached, twelve rounds of cell division after fertilization, the mid-blastula transition
(MBT) occurs (Jevtić and Levy, 2017). The MBT marks a number of changes in the embryo: cell
divisions become slower and asynchronous. Additionally, during this transition the embryo begins
to transcribe the zygotic genome. As soon as zygotic transcription occurs, the embryo begins to
generate components of major signaling networks that are necessary for gastrulation (Heasman,
2006).

1.3 Gastrulation- germ layer formation and patterning
In the amphibian embryo, gastrulation initiates when VegT, a maternally supplied factor,
stimulates expression of transcription factors, such as Bix4, to specify cells located in the vegetal
pole to differentiate into endoderm (Figure 1.1) (Casey et al., 1999; Horb and Thomsen, 1997;
Xanthos et al., 2001). VegT also activates nodal and nodal-related gene expression; these
transcripts encode proteins that induce cells in the region above the vegetal pole, called the
2

marginal zone, to differentiate as mesoderm (Figure 1.1) (Kofron et al., 1999; Xanthos et al.,
2001). The induction of mesoderm via the Activin/Nodal signaling pathway is known to be
conserved across vertebrate species including zebrafish, chicken, and mouse (Shen, 2007).

Animal pole

Organizer

Ventral

Dorsal

Marginal zone

Vegetal pole

Figure 1-1 Diagram of X. laevis embryo during early gastrulation
During gastrulation the three primary germ layers, endoderm, mesoderm, and ectoderm, begin to
differentiate. The vegetal pole refers to the lower hemisphere of the embryo and will give rise to
the endoderm. The marginal zone refers to the equatorial region of the embryo between the animal
and vegetal poles and will give rise to the mesoderm. The mesoderm contains a dorsal organizer
region which secretes BMP antagonists. The animal pole refers to the upper hemisphere of the
embryo which will give rise to the ectoderm. The drawing of the cavity in the animal hemisphere
depicts the fluid-filled blastocoel. As described in the text of this thesis, foxI1e, along with many
other germ layer-enriched factors, is expressed in the cells of the animal pole. chordin and
goosecoid are expressed in the dorsal marginal zone. wnt8 is expressed ventrolaterally and
brachyury is expressed throughout the marginal zone. vegT, an activator of nodal and nodal-like
genes, is expressed in the cells of the vegetal pole. The genes mentioned here are used throughout
this thesis as biomarkers for specific cell fates.
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Activin/Nodal signaling initiates when Nodal, Nodal-like, and other related Transforming Growth
Factor  (TGFβ) ligands bind to the type II TGFβ receptors, which subsequently phosphorylate
the type I receptors (Wylie and Heasman, 1997). The type I and type II receptors then form a
heterotetrameric complex, containing two of each receptor type. The activated type I receptors
phosphorylate

the receptor-activated

Smads

(R-Smads),

Smad2,

and Smad3.

Once

phosphorylated, Smad2 and Smad3 form a heteromeric complex with Smad4. This complex then
translocates from the cytoplasm to the nucleus and, along with many associated proteins such as
FoxHI, CREB binding protein, and Mixer, mediates the transcription of target genes (Chen et al.,
1997; Germain et al., 2000; Topper et al., 1998). Immediate-early targets of the Smad2/Smad4
complex include, among others, goosecoid and mix.2 (Chen et al., 1996; Germain et al., 2000;
Howell and Hill, 1997; Liu et al., 2011). High levels of Activin/Nodal signaling specify an
endodermal fate; lower levels of Activin/Nodal signaling specify a mesodermal fate (Gurdon et
al., 1994; Gurdon and Bourillot, 2001; Schier et al., 1997).

1.4 Additional pathways that specify mesoderm induction
In addition to the Activin/Nodal TGFβ pathway, several additional pathways are integral to
mesoderm induction and maintenance in the developing embryo. For example, Fibroblast Growth
Factor (FGF) signaling is required for the maintenance of mesoderm during gastrulation (Amaya
et al., 1993; Fletcher and Harland, 2008; Schulte-Merker and Smith, 1995). FGF and Brachyury
function through an autocatalytic loop; FGF induces expression of brachyury, which in turn
induces expression of eFGF (Kim et al., 1998). Brachyury, a T-box transcription factor, is an
immediate-early response to mesoderm induction and functions as an activator to turn on
additional mesodermal genes (Figure 1.1) (Kispert et al., 1995; Smith et al., 1991; Tada and Smith,
4

2000). Additionally, β-catenin stabilization is necessary for proper FGF signaling in the
prospective mesoderm during gastrulation (Moon, 2005; Schohl and Fagotto, 2003).

FGF induces mesoderm through various downstream signaling mechanisms. FGF signaling leads
to phosphorylation of the ERK mitogen-activated protein kinase (MAPK) pathway, which
subsequently leads to phosphorylation of P53 (Cordenonsi et al., 2007; Heasman, 2006). Once
phosphorylated, P53 physically associates with phosphorylated Smad2 to induce the expression of
mesodermal genes (Cordenonsi et al., 2003; Takebayashi-Suzuki et al., 2003). Studies in mouse
and mammalian cell culture show that independent from P53 phosphorylation, ERK also activates
expression of many factors critical for mesodermal maintenance (Ciruna and Rossant, 2001; Yang
et al., 2003). For example, ERK induces expression of Egr1, a transcription factor that regulates
expression of FGF target genes (Nentwich et al., 2009).

1.5

Differentiation and patterning of ectoderm

The cells of the ectoderm give rise to several distinct tissue types. Ventral ectoderm differentiates
into epidermal tissue, while neural tissue forms from the dorsal ectoderm; cells at the border
between these two populations develop into the sensory placodes and neural crest (Baker and
Bronner-Fraser, 2001; Mancilla and Mayor, 1996). During development, Bone Morphogenetic
Protein (BMP) signaling gradients regulate dorsal/ventral patterning of the mesoderm (Heasman,
2006). BMP signaling has been shown to also be critical for ectodermal patterning (Wilson and
Hemmati-Brivanlou, 1995). Studies have shown that an abundance of BMP4, a ligand that
stimulates the BMP signaling pathway and is initially widely expressed throughout the blastula,
ventralizes the ectoderm which then differentiates into epidermis (Wilson and HemmatiBrivanlou, 1995). The BMP signaling pathway increases the expression of many ventral-specific
5

transcription factors that specify a ventral fate (De Robertis and Kuroda, 2004; Onichtchouk et al.,
1996). For example, BMP4 is necessary and sufficient for the expression of the ventral-specific
transcription factor, Vent2 (Onichtchouk et al., 1996). The Spemann organizer secretes multiple
BMP antagonists that inhibit BMP signaling dorsally and allow dorsal ectodermal cells to adopt
their “default” fate, neural tissue; when BMP signaling is inhibited throughout the prospective
ectoderm, all ectodermal cells differentiate into neural tissue (Hawley et al., 1995; HemmatiBrivanlou and Thomsen, 1995; Lamb et al., 1993; Sasai et al., 1995; Weinstein and HemmatiBrivanlou, 1997). Classical studies suggest that the ectoderm forms because the cell population
overlying

the

blastocoel

does

not

receive

inducing

signals

to

differentiate

into

endoderm/mesoderm; i.e., Activin/Nodal signals do not diffuse beyond the blastocoel floor
(Heasman, 2006; Lee et al., 2001). Recent work, however, has demonstrated that there are proteins
expressed in the ectoderm necessary for active repression/restriction of mesodermal and
endodermal fates. Below, I describe the function of these factors, in detail. Activity of these factors
has been examined in various biological pathways. A list of factors with activity in one or more
pathways is provided in Table 1.
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Gene name

Blocks
mesoderm via
inhibition of
TGFβ
signal
transduction

Blocks mesoderm via
alternative pathway

Dand5 (Coco)

+

Additional
comments

References

Blocks via ligand
inhibition

Bell et al., Development
2003
Bates et al., Development
2013
Xu et al., Plos Biol 2012

Ndp (Norrin)

+

Tomoregulin-1
(TMEFF1)

+

Trim33 (Ectodermin)

+

Smad7

+

BAMBI

+

Inhibits
receptor/Smad
association

Serum Response Factor
(SRF)

+

Eaf1/2

+

Inhibits
FoxH1/Smad2
association
Associates with
Smad2 and P53

ZNF585B (XFDL156)

Blocks via ligand
inhibition
Inhibits
Cripto/receptor
complex
Promotes
degradation of
Smad4
Inhibitory Smad

+

P53 inhibitor

FoxI1e

+
+

Tbx2

+

Geminin

+

Transcriptional
activator
Transcriptional
repressor
PRC2 dependent

Ascl1

+

Recruits HDAC1

Table 1 Inhibitors of mesodermal gene expression in the ectoderm
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Chang et al., Dev. Biol.
2003
Dupont et al., Cell. 2005

Nakao et al., Nature
1997
Casellas et al., Dev. Biol.
1998
Onichtchouk et al.,
Nature 1999
Yan et al., J. Biol. Chem.
1999
Yun et al., Development
2007
Chen et al., Nature 1997
Liu et al., Biochim.
Biophys. Acta. Gene.
Regu.l Mech. 2017
Sasai et al., Cell 2008
Suri et al., Development
2005
Teegala et al., Dev. Dyn.
2018
Lim et al., Development
2011
Gao et al., Development
2016

1.6

TGFβ pathway inhibitors

Several of the proteins identified as necessary for repression of mesoderm and/or endoderm in the
ectoderm are inhibitors of the Activin/Nodal signaling pathway. One such inhibitor of
mesendoderm expression in the ectoderm, Dand5 (Coco), belongs to the Cerberus/DAN/Gremlin
superfamily. Members of this superfamily were originally identified as antagonists of BMPs
(Bouwmeester et al., 1996; Hsu et al., 1998; Piccolo et al., 1999). The BMP signaling pathway,
like the Nodal/Activin pathway, is a branch of the TGFβ signaling network; during development
in triploblastic organisms, BMP signaling ventralizes the gastrula (Hayward et al., 2002; Piccolo
et al., 1996; Schmidt et al., 1995; Suzuki et al., 1994; Weiss and Attisano, 2013). It was
subsequently determined that some members of the Cerberus/DAN/Gremlin superfamily function
as secreted inhibitors of both BMP and Activin/Nodal ligands, many of which are present in the
endoderm and mesoderm (Bouwmeester et al., 1996; Hsu et al., 1998; Piccolo et al., 1999). In the
ectoderm, Dand5 functions as a TGFβ ligand antagonist and, supplied maternally, is one of the
earliest expressed antagonists of TGFβ signaling (Figure 1.2) (Bell et al., 2003). In animal cap
explants, Dand5 physically associates with both BMP4 and Xnr1, ligands of the BMP and
Activin/Nodal pathways, respectively (Bell et al., 2003; Rahman et al., 2015; Zhou et al., 1993).
A population of pluripotent cells can be isolated from the animal pole of blastula stage X. laevis
embryos; this explant, called an “animal cap,” can be induced to differentiate into various tissue
types (Sive, 1993). Dand5 inhibits the mesoderm-inducing abilities of Xnr1 misexpression as well
as the ventralizing effects of BMP4 misexpression (Bell et al., 2003). The knockdown of Dand5
in animal caps leads to increased levels of phosphorylated Smad2 and increased expression of
mesodermal markers (Bates et al., 2013). Loss of Dand5 in whole embryos leads to increased
endodermal marker expression at the expense of mesoderm; the knockdown of dand5 in the
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presumptive mesoderm causes a reduction of the dorsal marker chordin (Bates et al., 2013). Loss
of Dand5 also leads to loss of Hoxb9, a spinal cord marker, suggesting the loss of Dand5
ventralizes the embryo (Bates et al., 2013). Overall, these experiments demonstrate that Dand5
inhibits both the BMP and Activin/Nodal branches of the TGFβ signaling pathway and is necessary
for repression of inappropriate mesendodermal gene expression in the ectoderm during
gastrulation (Bates et al., 2013; Bell et al., 2003).

Figure 1-2 Extracellular regulation of mesendodermal gene expression.
In this and subsequent figures, red boxes denote mesendoderm inhibitors. R-Smads refer to
Smads1/5/8 or Smads2/3 for the BMP and Activin/Nodal pathways, respectively. TGFβ ligands
(BMP4 and Activin/Nodal) bind the TGFβ receptor complex and activate signal transduction of
the TGFβ signaling pathway. Dand5 (Coco) and Ndp (Norrin) physically associate (independently
from one another) with BMP and Activin/Nodal and inhibit signal transduction.

At early cleavage stages, another maternal TGFβ ligand inhibitor, Ndp (Norrin), is expressed in
the prospective ectoderm (Bates et al., 2013). Ndp is a secreted protein characterized by a cysteineknot motif and was initially shown to function as a ligand in the Wnt signaling pathway (Berger
et al., 1992; Xu et al., 2004). Misexpression of ndp in animal caps represses Activin-mediated
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mesendoderm induction, and promotes neural fate, suggesting a repression of BMP signaling (Xu
et al., 2004). Co-immunoprecipitation experiments show that Ndp physically associates with the
BMP pathway ligand, BMP4, and, in cell culture experiments, the Activin/Nodal pathway ligand,
Xnr1 (Xu et al., 2004). These studies suggest that Ndp inhibits TGFβ signaling via association
with TGFβ ligands (Figure 1.2).

Another repressor of aberrant gene expression in the ectoderm is Tomoregulin-1 (TMEFF1), a
transmembrane protein (Chang et al., 2003; Harms and Chang, 2003). Misexpression of TMEFF1
suppresses Nodal- and Vg1- induced mesendoderm expression; TMEFF1 does not inhibit Activininduced mesendoderm (Chang et al., 2003). The association of Nodal with the type II and type I
TGFβ receptors and subsequent phosphorylation of Smad2 depends on a Cripto family co-receptor
(Yeo and Whitman, 2001). While important for signal transduction of the TGFβ pathway upon
Nodal ligand binding, Cripto has not been implicated in Activin signaling (Yeo and Whitman,
2001). Cripto physically associates with the TGFβ type I receptor and promotes the association of
Nodal and the type I receptor. TMEFF1 inhibits Nodal signaling by physically associating with
the type I co-receptor and preventing the type I co-receptor from forming a complex with Cripto,
an association necessary for signal transduction (Figure 1.3) (Harms and Chang, 2003).
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Figure 1-3 Transmembrane and cytosolic inhibition of mesendodermal gene expression.
TMEFF1, a transmembrane protein, prevents the association between Cripto, a Nodal-pathway
specific coreceptor, and the type I receptor. Smad7 inhibits TGFβ signaling by forming a complex
with Smurf2, which subsequently induces the degradation of the type I and type II TGF receptors.
BAMBI, another transmembrane protein, associates with Smad7 and the type I receptor and
inhibits association between the type I receptor and R-Smads. The “X” indicates the lack of a
serine/threonine intracellular kinase domain.

An additional inhibitor of TFG signaling during early development is BMP and Activin
Membrane-bound Inhibitor (BAMBI). BAMBI is a transmembrane protein with an extracellular
domain that is similar to that of the BMP type I receptor but lacks an intracellular serine/threonine
kinase domain (Onichtchouk et al., 1999). Misexpression of BAMBI in X. laevis animal caps is
sufficient to repress the effects of both BMP4 and Activin treatment (Onichtchouk et al., 1999).
BAMBI inhibits TGFβ signaling by associating with the type I and type II receptor complex
(Figure 1.3) (Onichtchouk et al., 1999). BAMBI decreases the phosphorylation level of the type I
receptor, and the homodimerization of type I receptors, necessary components of the TGFβ
signaling pathway (Luo and Lodish, 1996). Cell culture experiments show that BAMBI promotes
the formation of a ternary complex composed of Smad7, BAMBI, and the BMP type I receptor
11

(Figure 1.3) (Yan et al., 2009). In this case, BAMBI and Smad7 do not induce Smurf-mediated
receptor degradation (Yan et al., 2009); instead, the Smad7-BAMBI-type I receptor complex
inhibits the physical association between the type I receptor and R-Smads (Yan et al., 2009).

Another identified mechanism of mesoderm repression is via Smad4 inhibition. Smad4, an
intracellular mediator of TGFβ signaling, forms a heteromeric complex with Smad1/5/8 or
Smad2/3 in the BMP and Activin/Nodal pathways, respectively. As a downstream mediator of
both BMP and Activin/Nodal signaling, degradation of Smad4 inhibits signaling in both pathways
(Lagna et al., 1996). In the ectoderm, Trim33 (Ectodermin), a RING-type ubiquitin ligase,
physically associates with Smad4 (Figure 1.4) (Dupont et al., 2005). This association promotes the
degradation of Smad4 (Dupont et al., 2005). Loss of Trim33 in the prospective marginal zone of
X. laevis embryos expands the expression of endodermal markers, and loss of Trim33 in animal
cap explants induces expression of mesodermal markers (Dupont et al., 2005). Misexpression of
Trim33 in the prospective mesoderm represses mesodermal and ventral markers and increases the
expression of neural markers (Dupont et al., 2005). These data show that Trim33 is necessary for
inhibition of mesodermal and endodermal gene expression in the ectoderm.

An additional potent inhibitor of TGFβ signaling is Smad7, an “anti-Smad” (Nakao et al., 1997).
Misexpression experiments in X. laevis demonstrate that Smad7 is sufficient to reduce mesodermal
markers in both the mesoderm and in Activin-treated animal cap explants (Casellas and Brivanlou,
1998). Smad7 also inhibits the expression of ventral markers (Casellas and Brivanlou, 1998). This
indicates that Smad7 suppresses the Activin/Nodal and BMP pathways during gastrulation
(Casellas and Brivanlou, 1998; Nakao et al., 1997). Smad7 mediates this suppression through
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inhibition of R-Smad phosphorylation by the TGF receptors (Nakao et al., 1997). The exact
molecular mechanisms through which Smad7 inhibits TGFβ signaling have been demonstrated in
cell culture experiments. Smad7 physically associates with Smurf2 via a PPXY sequence in its
linker region. Smad7 regulates the localization of Smurf2; the Smurf2-Smad7 complex
translocates from the nucleus to the cytosol where it associates with a heteromeric type I and II
receptor complex (Figure 1.3) (Kavsak et al., 2000). Once associated with the TGFβ heteromeric
complex, Smurf2 induces degradation of the TGFβ receptors via both proteasomal and lysosomal
pathways (Kavsak et al., 2000). These data from cell culture experiments provide insight into how
Smad7 may function to inhibit mesodermal and endodermal gene expression during gastrulation.
Smad6, another anti-Smad, blocks BMP signaling in X. laevis (Hata et al., 1998; Imamura et al.,
1997; Onichtchouk et al., 1999). Studies in X. laevis have shown that smad6 overexpression
partially inhibits Activin-mediated mesoderm induction; however, the exact mechanism of this
repression is not well studied (Nakayama et al., 1998).

Regulation of TGFβ signaling also occurs downstream of the Smad2-Smad4 complex. The serum
response factor (SRF) belongs to the MADS-box family of transcription factors (Shore and
Sharrocks, 1995). MADS-box transcription factors contain a conserved 56 amino acid MADS-box
which confers DNA-binding activity (Shore and Sharrocks, 1995). During gastrulation, srf
transcripts are present predominantly in the ectoderm of X. laevis embryos, with low levels
detected in the marginal zone and no expression of SRF detected in the endoderm (Yun et al.,
2007). Loss-of-function studies demonstrate that SRF is necessary for the repression of
mesodermal markers in the ectoderm. Expression of a dominant-negative form of SRF in animal
cap explants of X. laevis embryos leads to ectopic expression of mesoderm (Shore and Sharrocks,
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1995). The knockdown of SRF in whole embryos leads to an expansion of mesodermal markers
towards the ectoderm (Shore and Sharrocks, 1995). An investigation into the mechanism of action
of SRF revealed that SRF represses mesoderm in the developing embryo by inhibiting the
association between Smad2 and Fast1 (Chen et al., 1997). Fast-1 (FoxH1) is a winged-helix
transcription factor that physically associates with Smad2 and functions as a co-activator to
positively regulate target genes (Chen et al., 1997, 1996). Through this mechanism, SRF functions
in the ectoderm to limit mesendoderm expression (Figure 1.4) (Yun et al., 2007).

Figure 1-4 Nuclear regulation of mesendodermal gene silencing.
Trim33 (Ectodermin) functions in the nucleus and, via ubiquitination, promotes the degradation of
Smad4. At the transcriptional level, SRF prevents association between FoxH1 and the Smad2Smad4 complex, repressing Smad2 target genes. Eaf1/2 are repressors that inhibit Activinmediated mesoderm induction via P53-dependent and P53-independent mechanisms. Eaf1/2
physically associate with P53, Smad2, Smad3, and FoxH1. ZNF585B (XFDL156) reduces the
amount of P53 bound to P53 target sites and represses P53-mediated mesodermal gene expression.
FoxI1e is an activator that likely indirectly inhibits mesendodermal gene expression in the
ectoderm. Tbx2, a T-box transcription factor, also represses mesendodermal gene expression.
Geminin is a chromatin modifier that represses gene expression by recruiting the PRC2 complex.
The PRC2 complex then trimethylates H3K27 to silence gene expression. Ascl1, another
chromatin modifier, recruits HDAC1 to deacetylate H3K27 and H3K9, a mechanism that silences
gene expression.
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Initially identified as tumor suppressors, Eaf1/2 have also been shown to inhibit phosphorylated
Smad2 activity during germ layer specification (Liu et al., 2017; Xiao et al., 2003). Eaf1/2 are
ELL-associated factors that were initially shown to function as antagonists of Wnt/β-catenin
signaling during development (Liu et al., 2013). During embryogenesis, Wnt/β-catenin plays an
important role in establishing the dorsoventral and anteroposterior axes of the embryo (Hikasa and
Sokol, 2013). Consistent with this, misexpression experiments in zebrafish demonstrate that
Eaf1/2 increase dorsal markers during gastrulation (Liu et al., 2013). Eaf1/2 function as
transcriptional repressors to inhibit Wnt/β-catenin signaling (Liu et al., 2013). Eaf1/2 were later
studied for their role in germ layer specification during gastrulation. Misexpression of Eaf1/2
reduces the expression of mesodermal and endodermal markers in zebrafish embryos. Loss of
function experiments show that the ectodermal marker foxi1 decreases in eaf1/2 morphants (Liu
et al., 2017). Studies in cell culture show that Eaf1/2 co-localize and physically associate with
Smad2. Chromatin immunoprecipitation experiments reveal that Eaf1/2 occupy promoters of
TGFβ targets, suggesting that Eaf1/2 function as transcriptional repressors, as they function in the
Wnt/β-catenin pathway, to repress the mesoderm-inducing activities of the Activin/Nodal branch
of the TGFβ signaling pathway, and specifically the function of Smad2 (Figure 1.4) (Liu et al.,
2017).

1.7 P53 inhibitors in mesoderm repression
P53 has been shown to induce mesoderm when overexpressed in animal cap explants of X. laevis
embryos; phosphorylated P53 physically associates with phosphorylated Smad2 to activate
mesodermal marker expression (Cordenonsi et al., 2007; Takebayashi-Suzuki et al., 2003).
Knockdown of P53 in eaf1/2 morphant zebrafish embryos reduces levels of mesodermal marker
expression, suggesting that Eaf1/2 may partially suppress mesodermal markers through a P5315

dependent mechanism (Liu et al., 2017). However, Eaf1/2 are still able to repress TGFβ targets
whose induction is independent of P53 function: Eaf1/2 suppress P53-independent targets of TGFβ
signaling in P53 mutant embryos (Liu et al., 2017). Studies also show that Eaf1/2 physically
associate with P53 and suppress Activin-induced luciferase activity downstream of P53 response
elements and P53-required TGFβ Luciferase reporters (Figure 1.4) (Liu et al., 2017). These data
suggest that Eaf1/2 function at the transcriptional level to repress P53-mediated mesoderm
induction (Liu et al., 2017).

Another inhibitor of P53-induced mesoderm expression is ZNF585B (XFDL156). ZNF585B is a
zinc finger nuclear factor present in X. laevis embryos in the ectoderm during early gastrulation
(Sasai et al., 2008). Misexpression experiments in animal cap explants reveal that ZNF585B
specifically represses mesodermal, and not endodermal, marker expression, suggesting that
ZNF585B does not function as a TFGβ pathway signaling inhibitor (Sasai et al., 2008). This led
to the discovery that ZNF585B functions as a P53 inhibitor; it physically associates with P53 and
decreases the level of P53 binding to target promoter sites (Figure 1.4) (Sasai et al., 2008). The Cterminus of P53 is referred to as the regulatory domain (RD); removal of this domain increases the
mesoderm-inducing ability of P53 (Cordenonsi et al., 2003; Takebayashi-Suzuki et al., 2003). The
deletion of the RD reduced the ability of ZNF585B to effectively inhibit mesoderm induction via
P53, indicating that the P53 RD is necessary for ZNF585B suppressor activity (Sasai et al., 2008).

1.8 Epigenetic suppressors of mesendoderm
In addition to the TGFβ pathway inhibitors and transcription factors described above, epigenetic
modifiers have been implicated in mesoderm and endoderm suppression. Geminin, a nuclear
protein, was initially identified as a regulator of DNA replication (McGarry and Kirschner, 1998).
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During gastrulation, Geminin promotes the expression of neural markers at the expense of
epidermal markers (Kroll et al., 1998). Misexpression of geminin suppressed both mesodermal and
endodermal markers in Activin- and FGF- treated animal cap explants. (Lim et al., 2011). The
knockdown of Geminin expands the expression patterns of mesodermal and endodermal genes;
however, the knockdown of Geminin in the animal pole of whole embryos is insufficient to induce
expression of mesodermal and endodermal markers (Lim et al., 2011). Geminin has been shown
to repress transcription through the Polycomb Repressive Complex 2 (PRC2); PRC2 is a cluster
of proteins that act as an epigenetic modulator to suppress transcription and has been implicated
in many biological processes including cell fate determination (Figure 1.4) (Margueron and
Reinberg, 2011; Schwartz and Pirrotta, 2013). Specifically, PRC2 functions as a methyltransferase
to trimethylate H3K27 and repress transcription (Cao et al., 2005). PRC2 is comprised of the
proteins Ezh2, Suz12, and Eed (Laugesen et al., 2016). Knockdown of either Suz12 or Ezh2
inhibits the repressive effects of Geminin misexpression, suggesting that an intact PRC2 is
necessary for Geminin function (Lim et al., 2011).

Another chromatin modifier implicated in repression of inappropriate gene expression in the
ectoderm is Ascl1. Ascl1 has been shown to neuralize mouse embryonic fibroblasts (Wapinski et
al., 2013). In X. laevis, Ascl1 inhibits VegT-mediated mesendoderm induction, but not
Activin/Nodal-mediated mesoderm induction. During gastrulation, VegT directly activates various
Nodal-related mesendoderm inducers (Clements et al., 1999; Heasman, 2006). Ascl1 is expressed
maternally, and during gastrulation is detected at high levels in the ectoderm and at lower levels
in the marginal zone (Gao et al., 2016). Experiments in both mammalian cell culture and X. laevis
embryos reveal that Ascl1 functions to recruit HDAC1 to reduce H3K27 acetylation, a marker of
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actively transcribed promoters (Figure 1.4) (Gao et al., 2016; Tie et al., 2009). Microinjection of
VegT increases levels of H3K27ac and H3K9ac (also a hallmark of active promoters) on
mesodermal and endodermal genes such as Nodal, and these levels are reduced by misexpression
of Ascl1 (Gao et al., 2016; Gates et al., 2017; Tie et al., 2009).

1.9 Additional transcriptional regulators of inappropriate germ layer
expression
The transcription factor, FoxI1e (Xema) is required for the suppression of mesendodermal
expression in the ectoderm during gastrulation (Figure 1.4) (Suri et al., 2005). The Fox
transcription factors are characterized by a conserved winged-helix DNA-binding domain, and
many are present during early embryogenesis (Pohl and Knöchel, 2005). Misexpression of FoxI1e
represses both Activin and FGF-mediated mesoderm induction, suggesting that FoxI1e may not
act directly, or at least not only, as a TGFβ pathway inhibitor (Suri et al., 2005). FoxI1e functions
as a transcriptional activator during early development (Suri et al., 2005). Expression of a chimeric
protein consisting of the FoxI1e coding region fused to an Engrailed repressor domain induces
mesodermal marker expression in animal cap explants, suggesting that repression of FoxI1e
transcriptional targets is sufficient to induce mesoderm (Suri et al., 2005). Misexpression of FoxI1e
in the endoderm induces the expression of both epidermal and neural ectodermal markers (Mir et
al., 2007). FoxI1e also plays a role in the spatial regulation of ectodermal cells: loss of FoxI1e
causes ectodermal cells to lose adhesive properties and relocate to other germ layers (Mir et al.,
2007).

As a transcriptional activator, it is likely that FoxI1e suppresses mesoderm indirectly, possibly
through activation of a transcriptional repressor responsible for suppressing mesodermal and
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endodermal gene expression in the ectoderm. tbx2, a gene encoding a T-box family transcription
factor, has been identified as a target of FoxI1e (Figure 1.4) (Teegala et al., 2018). The structure
of T-box proteins is conserved across five subfamilies (Papaioannou, 2014). All T-box proteins
contain a highly conserved region of 180–200 amino acids, called the T-box, which confers DNAbinding specificity (Wilson and Conlon, 2002). T-box proteins can function as activators or
repressors of transcription (Plageman and Yutzey, 2005; Zaragoza et al., 2004). Like foxi1e, tbx2
is expressed at high levels in the animal pole during gastrulation (Teegala et al., 2018). Also, like
FoxI1e, Tbx2 represses Activin and FGF-mediated mesoderm induction (Teegala et al., 2018).
However, unlike FoxI1e, Tbx2 functions as a transcriptional repressor (Teegala et al., 2018).
Misexpression experiments show that Tbx2 also represses ventral fate in animal cap explants and
induces expression of the “default” dorsal fate—neural tissue (Hemmati-Brivanlou and Melton,
1994, 1992; Teegala et al., 2018; Weinstein and Hemmati-Brivanlou, 1997). Ectopic expression
of Tbx2 in the marginal zone represses mesodermal and ventral markers (Reich et al., 2020). To
further demonstrate the repressive effect of Tbx2, the promoter region of bix4, a target of the Tbox transcription factors Brachyury and VegT, was fused to a Luciferase reporter gene. Bix4promoter/Luciferase experiments suggest that Tbx2 requires the T-box sites on the Bix4 promoter
for repression (Teegala et al., 2018). The ability of tbx2 to repress both BMP and Activin/Nodal
pathways suggests that Tbx2 may function through the TGFβ pathway and/or TGFβ target gene
inhibition; however, the ability of Tbx2 to repress FGF-mediated mesoderm induction suggests
that Tbx2 may additionally repress transcription through TGFβ-independent mechanisms. In this
thesis I will explore the mechanisms through which Tbx2 mediates germ layer suppression.
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1.10 Conclusion
Vertebrate germ layer formation and patterning is a complex process that involves both the
activation and suppression of multiple signaling pathways. Highlighted in this introduction are
several inhibitors of TGFβ signaling, necessary for repression of mesendodermal gene expression
in the presumptive ectoderm. These antagonists function at many steps in the pathway, from
ligand-receptor complex formation to TGFβ-mediated regulation of transcription. The requirement
for additional transcriptional repressors and chromatin modifiers demonstrates that inhibition at
multiple network nodes is necessary to restrict mesendoderm during gastrulation.

The restriction of mesendodermal gene expression in the animal pole and inhibition of BMP
signaling in the dorsal ectoderm during early development are sufficient to give rise to neural
tissue. These instances of gene repression are examples of a common theme found throughout
developmental biology, whereby localized inhibition of gene expression within the developing
embryo gives rise to “zones of plasticity” allowing distinct cell fates to arise. A somewhat
analogous process occurs during early post-implantation stages of mouse development. Initially
nodal is expressed throughout the epiblast and is necessary for proximal-distal patterning (Brennan
et al., 2001). Subsequently, during gastrulation, the anterior epiblast, fated to become ectoderm,
exhibits little Nodal signaling due to localized repression by multiple extracellular Nodal
antagonists (Tam et al., 2006). Studies in cell culture show that inhibition of Nodal signaling
specifies a transient ectodermal progenitor population that can give rise to either neural or
epidermal ectodermal fates (Li et al., 2015). This introduction highlights the process by which
multiple factors, via inhibition at multiple signaling nodes, specify a region devoid of
mesendoderm-inducing and ventralizing signals during gastrulation. In this thesis I will explore
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the mechanisms through which Tbx2 inhibits mesendoderm-inducing and ventralizing signals in
the ectoderm during gastrulation.
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2 Chapter II Materials and Methods
2.1 RNA preparation, explant dissection, and embryo culture
RNA was synthesized in vitro in the presence of cap analog using the mMessage mMachine kit
(Ambion). Microinjection, explant dissection, and embryo culture were performed as described
(Li et al., 2015). All constructs were injected at a concentration of 1ng/embryo except in the
experiments with tbx2NS1T or where indicated in the figure legend. For all animal cap and marginal
zone explant experiments, a minimum of five explants was used for each condition, and each
experiment was performed at least three times; results were consistent between all trials.

2.2

Construct preparation

To generate Myc-Tbx2ΔC, six Myc epitope tags were added upstream of a Tbx2ΔC construct, the
latter containing amino acids 1-518 of Tbx2 (Cho et al., 2011; Teegala et al., 2018). To generate
Tbx2ΔN, amino acids 54-688 were subcloned into pCS2++. For the Myc-Tbx2ΔN, DNA encoding
amino acids 54-688 were subcloned into pCS2MT (constructed by D. L. Turner and R. A. W.
Rupp).To generate Tbx2S1T-noNLS, DNA encoding amino acids 54-279 was subcloned into
pCS2++. To generate Myc-Tbx2S1T-noNLS, the same sequence was subcloned into pCS2MT. For
Tbx2NS1T, amino acids 290-688 were deleted from Tbx2 in pCS2+. The same amino acids were
deleted from Myc-Tbx2 to generate Myc-Tbx2NS1T (Genewiz). In this construct and all
subsequent constructs with the Tbx2 T-box at the C terminus, ten amino acids from spacer 2 were
added to include the nuclear localization sequence (Carlson et al., 2001). To generate Tbx2TS2C,
amino acids 1-54 were deleted from Tbx2 in pCS2+. The same amino acids were deleted in Myc-
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Tbx2 to generate Myc-Tbx2TS2C (Genewiz). To construct Tbx2S1T and Myc-Tbx2S1T, amino
acids 290-688 were deleted from Tbx2ΔN and Myc-Tbx2ΔN, respectively. Myc-Tbx2R-A was
generated by a single amino acid mutation of Arginine 122 to Alanine (AGG to GCT) in MycTbx2 (Genewiz) (Sinha et al., 2000). Flag-Smad2 was purchased from Addgene (plasmid #14042).
Flag-Smad4 was a gift from Dr. Gerald Thomsen (Kavsak et al., 2000). Tbx2-DBD-VP16 was
previously described (Teegala et al., 2018). To generate Flag-tagged H2A constructs, Flag-tagged
hH2A was subcloned into the pCS2++ vector from pCDNA3.1-Flag-H2A (Flag-hH2A) (Mattiroli
et al., 2012). To generate Flag-xH2A, Flag-xH2A.X, and Flag-xH2A.Z, the sequence for hH2A
was removed from Flag-hH2A and replaced with sequences for xH2A, xH2A.X, or xH2A.Z (FlagxH2A, Flag-xH2A.X, Flag-xH2A.Z). In all H2A constructs, the “h” and “x” refers to human and
X. laevis, respectively. The nucleotide sequences for each of these H2A constructs were
synthesized de novo and inserted in frame with the Flag tag (Genscript). To generate HA-tagged
H2A constructs, the Flag tag was removed from Flag-xH2A, Flag-xH2A.X, and Flag-xH2A.Z
constructs and replaced with an HA-tag (HA-xH2A, HA-xH2A.X, HA-xH2A.Z, respectively)
(Genscript).

2.3 Cycloheximide assays
X. laevis embryos were injected at the two-cell stage with 1ng of tbx2-DBD-Vp16. Animal caps
were explanted at stage 8 and incubated in 10ug/ml of cycloheximide until early gastrula stages.
Animal cap explants were then harvested and RNA was extracted in preparation for RT-PCR.
Each sample contained 5 animal caps.
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2.4 Reverse transcription-polymerase chain reaction (RT-PCR)
X. laevis embryos were staged according to Nieuwkoop and Faber, 1967 and harvested at
appropriate stages according to morphological criteria. RNA was prepared using RNA Bee RNA
isolation reagent (Tel-Test Inc.). RT-PCR was performed as described (Wilson and HemmatiBrivanlou, 1995). All primer sequences are as described: ODC, Xbra, Wnt8, chordin, and
goosecoid (Suri et al., 2005); sizzled1 (Sridharan et al., 2012); sizzled2 (Jin and Weinstein, 2018);
bmp4 (Fainsod et al., 1997); Xvent2 (Miyazaki et al., 2012); bix4 (Teegala et al., 2018); derriere
(Sun et al., 1999); Xwnt11 (Afouda and Hoppler, 2011).

2.5 Western blot analysis
Western blot analysis was performed largely as described (Hama et al., 2002). Animal caps (1015 per condition) were lysed in 5ul/animal cap of lysis buffer (150mM NaCl, 20mM Tris pH 7.5,
1% Nonidet P-40, 1mM EDTA, and 1 protease and phosphatase inhibitor tablet/10 ml of buffer)
(Thermofisher) (Hama et al., 2002). After incubation on ice for 30 minutes, animal cap lysates
were centrifuged at 4°C for 5 minutes at 14,000g. Clear supernatant was retained. 5-15 ul of
supernatant was run for each sample. Antibodies against phospho-Smad1/5 (S463/465) (Cell
Signaling Technology), Smad1 (Cell Signaling Technology), Phospho-Smad2 (S465/467) (Cell
signaling technology), Smad2/3 (Cell signaling technology) and GAPDH (Sigma) were all used at
1:1000 dilution. Secondary antibodies (donkey anti-rabbit IgG, or donkey anti-mouse IgG)
coupled to horseradish peroxidase (Jackson ImmunoResearch) were used at 1:10,000 dilution.
Bands were subjected to densitometric analysis and graphed.
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2.6 Co-immunoprecipitation
RNA from all Myc-tagged constructs was injected into early cleavage stages embryos. Injected
embryos were harvested at late gastrula stages. Co-immunoprecipitation experiments were
performed largely as described (Hama et al., 2002). Embryos were lysed in 10ul/embryo of lysis
buffer (150mM NaCl, 20mM Tris pH 7.5, 1% Nonidet P-40, 1mM EDTA, and 1 protease inhibitor
tablet/10 ml of buffer) (Thermofisher) (Hama et al., 2002). After incubation on ice for 30 minutes,
embryo lysates were centrifuged at 4°C for 5 minutes at 14,000g. Clear supernatant was retained
and then split equally into control and experimental samples. 10 ul of clear supernatant was
removed as “input” from each sample. Embryo lysates were incubated with rotation overnight at
4°C with either anti-Smad1 (333 µg/ml), anti-Flag (800 µg/ml), or anti-Myc (7.4mg/ml) antibodies
at 1:150 dilution, normal Rabbit IgG (1 mg/ml) with the IgG normalized to experimental samples
and Mouse IgG1 (2.5mg/ml) with the IgG1 normalized to experimental samples) (Cell Signaling
Technology), followed by incubation with Dynabeads Protein G (Novex) with rotation at 4°C for
one hour. Samples were washed 6 times with 200 ul of lysis buffer and eluted with 20ul of 1X
NuPage LDS sample buffer and 5ul of .5M dithiothreitol. The elution was subject to SDS-PAGE.
Antibodies against Myc (Sigma), Flag (Sigma), HA (Cell Signaling), and Smad1 (Cell Signaling)
were used to probe the blot at 1:1000 dilution. Secondary antibodies (donkey anti-mouse IgG or
donkey anti-rabbit IgG) coupled to horseradish peroxidase (Jackson ImmunoResearch) were used
at 1:10,000 dilution.

2.7 Immunoprecipitation-mass spectrometry
210 embryos were injected in the animal pole at early cleavage stages, each with 1ng of mycTbx2 and collected at mid-gastrula stages. Myc-Tbx2 was immunoprecipitated with an anti-Myc
antibody (Sigma-Aldrich) or an IgG1 control antibody (Cell Signaling). The samples were sent to
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MS Bioworks and run on an SDS-PAGE gel. Bands were excised and analyzed by nano-liquid
chromatography-tandem mass spectrometry (LC-MS/MS). Proteins were identified by Mascot
and protein visualization and validation was performed using Scaffold.
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3 Chapter III: Tbx2 mediates dorsal patterning and germ layer
suppression through inhibition of BMP/GDF and Activin/Nodal
signaling
3.1

Introduction

T-box proteins are an evolutionarily conserved family of transcription factors critical for a number
of processes during development (Showell et al., 2004). The first identified T-box protein, T,
encoded by brachyury, induces mesoderm in the early mammalian embryo (Kispert et al., 1995).
In the mouse, a homozygous loss-of-function mutation in brachyury is embryonically lethal,
highlighting the importance of T-box proteins in early development (Gluecksohn-Schoenheimer,
1938). T-box proteins have also been implicated in development of craniofacial tissue, liver, heart,
and lung (Christoffels et al., 2004; Dastjerdi et al., 2007; Lüdtke et al., 2013, 2009; Xanthos et al.,
2001).

The T-box proteins are comprised of five subfamilies; all contain a highly conserved region of
180-200 amino acids, called the T-box, which confers DNA binding specificity (Papaioannou,
2014; Wilson and Conlon, 2002). Many T-box proteins have been shown to bind the core T-box
binding element TCACACCT (Wilson and Conlon, 2002). T-box proteins bind to DNA as either
monomers or dimers, depending on the protein, and can function as activators or repressors of
transcription (Conlon et al., 2001). Activator and repressor domains have been identified in the
carboxyl (C)- or amino (N)- termini of T-box proteins (Plageman and Yutzey, 2005; Zaragoza et
al., 2004).

Two well-studied T-box proteins, Brachyury, mentioned above, and VegT, mentioned previously,
are necessary for formation and patterning of mesoderm and endoderm, respectively; both function
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as transcriptional activators in this context (Herrmann et al., 1990; Xanthos et al., 2001). Our lab
has recently shown that Tbx2 functions in the ectoderm as a transcriptional repressor during
gastrulation (Teegala et al., 2018). When tbx2 is knocked down in the presumptive ectoderm,
ectopic mesendoderm--a transient, precursor cell population from which both mesoderm and
endoderm emerge during gastrulation-- forms (Charney et al., 2017). Moreover, ectopic Tbx2
suppresses mesendoderm in animal cap explants exposed to Activin or basic Fibroblast Growth
Factor (bFGF) (Teegala et al., 2018). To date, however, little is known about the mechanisms
through which Tbx2 promotes mesendoderm repression.

The population of cells in the ectoderm develops into several distinct tissue types. Ventral
ectoderm differentiates into epidermis, while the dorsal ectoderm gives rise to neural tissue
(Wilson and Hemmati-Brivanlou, 1995); cells at the border of these two populations develop into
the sensory placodes and neural crest (Baker and Bronner-Fraser, 2001; Mancilla and Mayor,
1996). Bone Morphogenetic Protein-4 (BMP-4), expressed throughout the ectoderm, ventralizes
the ectoderm, which subsequently differentiates into epidermis (Weinstein and HemmatiBrivanlou, 1997). Dorsally, at the initiation of gastrulation, the Spemann organizer secretes BMP
antagonists allowing proximal ectodermal cells to adopt a dorsal, neural fate (Weinstein and
Hemmati-Brivanlou, 1997). Tbx2 misexpression also dorsalizes ectoderm, resulting in
neuralization; this effect is accompanied by downregulation of Bone Morphogenetic Protein
(BMP) activity (Teegala et al., 2018).

Tbx2 thus appears to suppress signaling through both the Activin/Nodal and BMP/GDF branches
of the TGFβ pathway. In canonical TGFβ signaling, upon ligand binding, the TGFβ type II
receptors phosphorylate the TGFβ type I receptors, which propagates the signal and
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phosphorylates the carboxyl terminus of the intracellular signal transducers Smad1/5 or Smad2/3,
downstream of BMP/GDF or Activin/Nodal ligands, respectively (Abdollah et al., 1997; Wrana et
al., 1994). These receptor-mediated Smads then form a heteromeric complex with Smad4 which
translocates to the nucleus where it associates with transcription factors to regulate gene expression
(Abdollah et al., 1997).

The discovery that Tbx2 has a global impact on TGFβ signaling prompted us to examine more
directly the relationship between Tbx2 and components of the Activin/Nodal and BMP/GDF
networks. Here we report that Tbx2 physically associates with both Smad1 and Smad2, essential
intracellular mediators of BMP and Nodal signaling, respectively. Deletion analysis of the Tbx2
protein identified the T-box DNA-binding domain as sufficient for Tbx2-Smad binding. Structurefunction analyses suggest a model in which Tbx2 regulates interaction of Smads and Smadinteracting proteins in the nucleus.

3.2 Results
3.2.1 Tbx2 physically associates with multiple Smad proteins
We have previously reported that Tbx2 inhibits mesoderm induction in animal cap explants treated
with either basic Fibroblast Growth Factor (bFGF) or the TGFβ ligand Activin (Teegala et al.,
2018). We find that misexpression of Tbx2 also inhibits expression of the panmesodermal marker
brachyury in ventral and dorsal marginal zone explants, indicating that Tbx2 represses mesoderm
formation in the context of the embryo (Figure 3.1) (Smith et al., 1991). Notably, ventral marginal
zone explants show an increase in the dorsal markers chordin and goosecoid and repression of the
ventral marker wnt8, demonstrating that Tbx2 has a dorsalizing effect on the mesoderm, as well
as the ectoderm (Cho et al., 1991; Christian et al., 1991; Sasai et al., 1994; Teegala et al., 2018)
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(Figure 3.1). These and earlier published studies suggest that Tbx2 inhibits both Activin/Nodal
and BMP/GDF signaling in the early embryo (Teegala et al., 2018). This raised the prospect that
Tbx2 may inhibit TGFβ signaling via direct interaction with TGFβ signaling transducers.

Figure 3-1 Tbx2 dorsalizes ventral mesoderm.
RT-PCR analysis of marginal zone explants. Embryos were injected radially at early cleavage
stages with 1ng of tbx2; marginal zone explants were dissected at stage 10.
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To address this possibility of direct interaction between Tbx2 and intracellular components of the
TGFβ signaling network, we first examined whether Tbx2 physically associates with the Smad1
and Smad2 proteins, branch-specific mediators of BMP/GDF and Activin/Nodal signaling,
respectively. As we have not been able to obtain an antibody that recognizes native Tbx2, we
generated a Myc-epitope-tagged Tbx2 construct (Myc-Tbx2), and injected myc-tbx2 synthetic
RNA into early cleavage stage embryos. Immunoprecipitation and Western blot analysis
demonstrate that native Smad1 physically associates with exogenous Tbx2 in Xenopus embryos
(Figure 3.2 A). We have not been able to detect native Xenopus Smad2 following
immunoprecipitation using commercially-available antibodies; thus, we next co-injected myc-tbx2
and flag-smad2 synthetic RNA into early cleavage stage embryos. Physical association between
exogenous Smad2 and Tbx2 in X. laevis embryos was observed (Figure 3.2 B). Tbx2 inhibits
mesodermal marker gene expression stimulated by Smad2, consistent with a physiological role for
Tbx2-Smad2 interaction during germ layer differentiation (Figure 3.2 C).
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Figure 3-2 Tbx2 associates with R-Smads.
A) Tbx2 physically associates with Smad1. 1 ng myc-tbx2 RNA was injected at early cleavage
stages. Pull-down of native Smad1 from injected embryos leads to co-immunoprecipitation of
exogenous Tbx2. Normal rabbit IgG antibodies were used in parallel studies as a negative control.
B) Tbx2 physically associates with Smad2. 1ng of myc-tbx2 and 1ng of flag-smad2 were injected
at early cleavage stages. Pull-down of Flag-Smad2 from injected embryos leads to coimmunoprecipitation of exogenous Tbx2. Normal rabbit IgG antibodies were used in parallel
studies as a negative control C) Tbx2 represses Smad2-mediated mesoderm induction. Embryos
were injected with tbx2 (1ng), flag-smad2 (1ng), or tbx2 (1ng) and flag-smad2 (1ng) at the twocell stage and animal caps were explanted at stage 8.5. Tbx2 represses Smad2-induced mesoderm.
D) Tbx2 physically associates with Smad4. 1ng of myc-tbx2 and 1ng of flag-smad4 were injected
at early cleavage stages. Pull-down of Flag-Smad4 from injected embryos leads to coimmunoprecipitation of exogenous Tbx2. Normal rabbit IgG antibodies were used in parallel
studies as a negative control.
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Following pathway-specific activation, both branches of the TGFβ pathway converge on the “coSmad” Smad4, which associates with C-terminally phosphorylated forms of both Smad1 and
Smad2 (Lagna et al., 1996). As with Smad1 and Smad2, exogenous Tbx2 physically associates
with Flag epitope-tagged human Smad4 (Figure 3.2 D). Taken together, these studies demonstrate
that Tbx2 associates with both pathway-specific and pathway-shared Smad proteins. Additionally,
these data indicate that Tbx2 is unlikely to inhibit TGFβ signaling via sequestration of R-Smads
from Smad4.

3.2.2

Identification of the Tbx2 domain sufficient for R-Smad association

Our determination of interactions between Tbx2 and Smad proteins prompted us to ask whether
these associations are central to Tbx2’s role in suppression of ventral and/or extraectodermal fate.
To determine whether Tbx2 requires interaction with Smad1 and Smad2 to mediate dorsoventral
patterning or mesendodermal suppression, respectively, we first sought to identify the domains of
Tbx2 protein required for Smad interaction. Toward this end, we constructed multiple Tbx2
deletion constructs, tagged with a Myc epitope (Figure 3.3). These deletion constructs were
designed so that each construct lacks one or more domains of Tbx2, with the goal of eliminating
the region necessary for R-Smad interaction. Following injection of RNA encoding these
constructs, we performed immunoprecipitation assays using either a Smad1 antibody or, after coinjection of myc-tbx2 and flag-smad2, a Flag epitope-specific antibody, followed by SDS-PAGE
and Western blotting with an anti-Myc antibody. These studies identify the T-box region as
sufficient for association with either Smad1 or Smad2; deletion of the N or C termini had no effect
on R-Smad association. Tbx2 constructs with the first or second spacer deleted also associated
with both Smad1 and Smad2 ((Figure 3.4 A-J).
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Figure 3-3 Depictions of Myc-tagged Tbx2 deletion constructs
“Myc” refers to a 6x Myc epitope tag. N and C refer to the N and C termini, respectively. S 1 and
S2 refer to the first and second spacer, respectively.

Figure 3-4 The Tbx2 Spacer 1 and T-box domains are sufficient for R-Smad association.
A-E) Smad1 physically associates with Tbx2 via the T-box. Embryos were injected at the twocell stage with 1ng of RNA synthesized from the indicated deletion construct. Pull-down of native
Smad1 from injected embryos leads to co-immunoprecipitation of the exogenous deletion
construct. Normal rabbit IgG antibodies were used in parallel studies as a negative control. F-J)
Smad2 physically associates with Tbx2 via the T-box. Embryos were injected at the two-cell stage
with 1ng of RNA synthesized from the indicated deletion construct and flag-smad2. Pull-down of
Flag-Smad2 from injected embryos leads to co-immunoprecipitation of the exogenous deletion
construct. Normal rabbit IgG antibodies were used in parallel studies as a negative control.
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3.2.3

Activity of deletion constructs

Because the region of Smad association is within the T-box, we questioned whether the smallest
construct that contained the T-box has activity. We expected this construct, Tbx2S1T, to function,
if at all, like Tbx2ΔC as both lack a previously identified C-terminal repressor domain. Previous
work from our lab showed that Tbx2ΔC does not repress Activin-mediated mesoderm expression
(Teegala et al., 2018). To test the activity of Tbx2S1T, we used an embryological explant assay.
Animal caps were explanted at stage 8.5 from embryos injected at the 2-cell stage with RNA
transcribed from Tbx2S1T and cultured until stage 11 in the presence or absence of Activin. These
samples were then assayed for mesodermal gene expression. To our surprise, this construct
repressed Smad2/Activin-mediated mesoderm induction in animal caps, suggesting the presence
of a second, previously unidentified repressor domain in Tbx2S1T (Figure 3.5 A). Unlike fulllength Tbx2, misexpression of this construct did not repress all ventral markers; Vent2 was not
repressed, while repression of Szl was sometimes observed, indicating that complete ventral
repression may require an as-yet undefined composite of domains (Figure 3.5 A, data not shown).
Alternatively, it is possible that a higher concentration of tbx2S1T is required for ventral than for
mesodermal repression.
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Figure 3-5 Effects of Tbx2 deletion constructs on the BMP/GDF and Activin/Nodal
pathways.
A) Embryos were injected with 2ng of tbx2 or tbx2S1T in the animal pole at the two-cell stage.
Animal caps were explanted at stage 8.5. Activin was added (2.5ng/ml) as indicated. B) Embryos
were injected with 2ng of tbx2 or tbx2NS1T in the animal pole at the two-cell stage. Animal caps
were explanted at stage 8.5. Activin was added (2.5ng/ml) as indicated. C) Embryos were
injected with 2ng of tbx2 or tbx2NS1T in the animal pole at the two-cell stage. Animal caps were
explanted at stage 8.5. D) Embryos were injected with 1ng tbx2 or tbx2ΔN in the animal pole at
the two-cell stage. Animal caps were explanted at stage 8.5. Activin was added (2.5ng/ml) as
indicated E) Embryos were injected with 1ng tbx2 or tbx2TS2C in the animal pole at the two-cell
stage. Animal caps were explanted at stage 8.5. Activin was added (2.5ng/ml) as indicated.
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This result led us to question why the presumed second Smad2/Activin repressor domain is not
active in Tbx2ΔC. We hypothesize that there is a region present in Tbx2ΔC that functions as either
an activator domain or an inhibitor of the second repressor domain. To test this possibility, we
injected RNA transcribed from the construct missing both the C-terminus and the second spacer,
Tbx2NS1T, into two-cell stage embryos. Animal caps were explanted at stage 8.5 and cultured in
the presence or absence of Activin. Animal caps injected with tbx2NS1T RNA did not repress
Activin-mediated mesoderm induction or ventral markers (Figure 3.5 B,C). These data supports
our hypothesis, and indicates that the presence of the N-terminus inhibits activity of the repressor
located in Tbx2S1T. Deletion of only the N-terminus has no effect on Tbx2 activity; animal caps
explanted from embryos injected with RNA transcribed from Tbx2ΔN did not express mesodermal
markers in the presence of Activin (Figure 3.5 D). Finally, RNA transcribed from Tbx2TS2C, was
injected and assayed for activity. This construct functions like the full length Tbx2 in both the
Smad1/BMP and Smad2/Activin pathways (Figure 3.5 E). These results indicate that a construct
containing the T-box, second spacer, and C-terminus renders the N-terminus and the first spacer
unnecessary for wild-type repression of both the Activin/Nodal and BMP/GDF pathways (Figure
3.5 E).

3.2.4 The Tbx2 nuclear localization sequence is necessary for Tbx2-Smad1 association
Eomesodermin, a T-box transcription factor that physically associates with Smad2, is detected in
both the nucleus and cytoplasm; we thus wondered whether Tbx2 associates with R-Smads in the
plasma membrane (Picozzi et al., 2009). To explore this possibility, we removed the nuclear
localization signal from the Myc-Tbx2S1T (Myc-Tbx2S1T-NoNLS) construct and injected mycTbx2S1T-noNLS into early cleavage embryos. Upon pulldown with an anti-Smad1 antibody and
subsequent western blot, no Myc-Tbx2S1T-NoNLS was detected (Figure 3.6 A). This suggests
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that upon removal of the NLS, Myc-Tbx2S1T-NoNLS does not physically associate with Smad1.
Additionally, removal of the nuclear localization signal renders Tbx2S 1T inactive (Figure 3.6 B).
Immunoprecipitation of Flag-Smad2 and subsequent Western blot analysis of embryos injected
with 1ng of myc-Tbx2S1T-NoNLS and 1ng of flag-Smad2 demonstrates that Flag-Smad2 associates
with Myc-Tbx2S1T-NoNLS (Figure 3.6 C). This suggests that Tbx2 associates with Flag-Smad2
outside of the nucleus, however, it is possible that an abundance of exogenous Flag-Smad2
facilitates cytoplasmic Smad2-Tbx2S1T-NoNLS association.
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Figure 3-6 Embryological activity and R-Smad association of Tbx2S1T-NoNLS.
A) Tbx2S1T-NoNLS does not physically associate with Smad1. 1 ng myc-tbx2S1T-NoNLS RNA
was injected at early cleavage stages. Pull-down of native Smad1 from injected embryos does not
lead to co-immunoprecipitation of exogenous Tbx2S1T-NoNLS. Normal rabbit IgG antibodies
were used in parallel studies as a negative control. B) Tbx2S1T-NoNLS does not repress
mesodermal markers. Embryos were injected with 1ng of tbx2S1T-NoNLS at the two-cell stage and
animal caps were explanted at stage 8.5 and incubated with Activin (2.5 ng/ml) as indicated. C)
Tbx2S1T-NoNLS physically associates with Smad2. 1 ng myc-tbx2S1T-NoNLS and 1ng of flagSmad2 were injected at early cleavage stages. Pull-down of Flag-Smad2 from injected embryos
leads to co-immunoprecipitation of exogenous Tbx2S1T-NoNLS. Normal rabbit IgG antibodies
were used in parallel studies as a negative control.
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3.2.5

Tbx2 regulation of Smad C-terminal phosphorylation

As mentioned above, TGFβ-induced nuclear accumulation and activation of Smad1 and Smad2 is
mediated by phosphorylation of Serine residues at their C-termini (Macías-Silva et al., 1996). We
reasoned that Tbx2 might inhibit Smad activation via inhibition of Smad C-terminal
phosphorylation. To test this possibility, animal cap explants derived from embryos injected with
tbx2 and cultured in the presence or absence of Activin were assayed at gastrula stages for
embryological activity and for Smad C-terminal phosphorylation by Western blotting (Cell
Signaling) (Simeoni and Gurdon, 2007). Uninjected embryos were processed in parallel. Notably,
we found that Tbx2 does not decrease Smad2 phosphorylation levels in the presence of Activin,
indicating that Tbx2 does not inhibit Activin/Nodal signaling through hypophosphorylation of
Smad2 C-terminal Serine residues (Figure 3.7 A). Similar experiments were performed to examine
the potential regulation by Tbx2 on Smad1 C-terminal phosphorylation. In these studies, Smad1
C-terminal phosphorylation was similarly unaffected by the presence of ectopic Tbx2 (Figure 3.7
B,C). These studies demonstrate that Tbx2 does not inhibit TGFβ signaling via C-terminal
dephosphorylation of Smad1 or Smad2.
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Figure 3-7 Tbx2 does not decrease levels of C-terminal phosphorylation of Smad1 and
Smad2.
A) Embryos were injected with 1ng tbx2 at the two-cell stage; animal caps were explanted at stage
8.5 and incubated in Activin (2.5 ng/ml), as indicated, until late gastrula stages. Uninjected
embryos were used in parallel studies. B) Embryos were injected with 1ng tbx2 at the two-cell
stage and animal caps were explanted at stage 8.5 and incubated until late gastrula stages.
Uninjected embryos were used in parallel studies. C) Quantification of data shown in B, indicating
no change in Smad1 protein levels or phosphorylation of Smad1 as a result of ectopic tbx2
expression.

3.2.6 Tbx2 activity requires Arginine 122
The T-box protein Tbx20 mediates repressor activity independent of DNA binding (Singh et al.,
2009). We therefore questioned whether DNA-binding was necessary for Tbx2 activity. We thus
attempted to separate the DNA binding activity of Tbx2 from the physical association of Tbx2
with R-Smads. Previous studies of T-box proteins have shown that Arginine 122 is necessary for
Tbx2 DNA-binding activity (Sinha et al., 2000). An Arginine to Alanine mutation in the T-box of
Myc-Tbx2 (Myc-Tbx2R-A) abolishes repressor activity in both the BMP/GDF and Activin/Nodal
branches of the TGFβ pathway (Figure 3.8 A). Co-immunoprecipitaion experiments with Myctagged Tbx2R-A, Smad1, and Smad2 show that Tbx2 associates with R-Smads even when DNAbinding activity is abolished (Figure 3.8 B,C). These data indicate that Tbx2 physically associates
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with R-Smads independent of DNA-binding, and that this interaction is not sufficient for
repression of TGFβ signaling.

Figure 3-8 DNA binding is necessary for Tbx2 repressor activity.
A) RT-PCR analysis of animal cap explants injected with Tbx2 DNA binding mutant construct.
Embryos were injected with 1ng myc-tbx2R-A or myc-tbx2 at the two-cell stage; animal caps were
explanted at stage 8.5 and incubated in Activin (2.5 ng/ml) where indicated until late gastrula
stages. B) Smad1 physically associates with Tbx2R-A. Embryos were injected at the two-cell stage
with 1ng of RNA synthesized from Myc-Tbx2R-A. Pull-down of native Smad1 from injected
embryos leads to co-immunoprecipitation of exogenous Myc-Tbx2R-A. Normal rabbit IgG
antibodies was used in parallel studies as a negative control. C) Smad2 physically associates with
Myc-Tbx2R-A. Embryos were injected at the two-cell stage with 1ng myc-tbx2R-A and 1 ng flagsmad2. Pull-down of Flag-Smad2 from injected embryos leads to co-immunoprecipitation of
exogenous Myc-Tbx2R-A. Normal rabbit IgG antibodies were used in parallel studies as a
negative control.
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3.2.7 Identification of Tbx2 direct targets
As described above, we have shown that Tbx2 DNA-binding activity is necessary for Tbx2mediated gene repression (Figure 3.8A). To further define the direct targets to which Tbx2 binds,
we utilized a pharmacological assay. Cycloheximide is a compound that interferes with translation
elongation by inhibiting translocation of deacetylated tRNA during eukaryotic protein synthesis
and is commonly used to identify direct targets of transcription factors (Engleka et al., 2001;
Klinge et al., 2011; Obrig et al., 1971; Schneider-Poetsch et al., 2010). In the presence of
cycloheximide, increases of gene expression of direct transcriptional targets only are observed;
inhibition of translation of intermediary transactivators blocks increases in expression of indirect
transcriptional target genes. .

Because Tbx2 is a repressor, the overexpression of Tbx2 in the animal pole would not cause a
notable change in gene expression in the presence of cycloheximide; the genes that Tbx2 is known
to repress are not expressed in the ectoderm (Teegala et al., 2018). Therefore, to identify Tbx2
target genes, we utilized a construct in which the DNA-binding domain of Tbx2 is fused to a VP16
activation domain (Tbx2-DBD-VP16) (Teegala et al., 2018). Tbx2-DBD-VP16 functions as an
activator and activates genes repressed by overexpression of Tbx2 (Teegala et al., 2018). Early
cleavage embryos were injected with 1ng of tbx2-DBD-VP16 and animal caps were explanted at
stage 8. These explants were incubated in the presence or absence of cycloheximide and harvested
at early gastrula stages. Promoter analysis experiments suggest that Bix4 is a direct target of Tbx2;
site-directed mutagenesis of multiple T-box sites on the Bix4 promoter inhibit Tbx2-mediated
Bix4 repression, suggesting that Tbx2 represses Bix4 through multiple T-box sites on the Bix4
promoter (Teegala et al., 2018). The cycloheximide-treated samples, along with control samples,
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were assayed for expression of bix4 and other known T-box transcription factor targets derriere
and wnt11 (Casey et al., 1999; Tada and Smith, 2000; White et al., 2002). As expected, Tbx2DBD-VP16 directly activates these target genes (Figure 3.9). In addition, wnt8, a ventral
mesodermal marker repressed by Tbx2, is activated by Tbx2-DBD-VP16 in the presence of
cycloheximde, suggesting that it is a direct target of Tbx2 (Figure 3.9). chordin activation by Tbx2DBD-VP16 is inhibited by cycloheximide, suggesting that it is an indirect target of Tbx2 (Figure
3.9). Cycloheximide alone increases transcription of xbra and gsc; we therefore cannot determine
if they are direct targets of Tbx2-DBD-VP16 in this assay (Kurth et al., 2005; Tadano et al., 1993).
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Figure 3-9 Direct targets of Tbx2-DBD-VP16
RT-PCR analysis of animal cap explants injected with tbx2-DBD-VP16. Embryos were injected
with 1ng tbx2-DBD-VP16 at the two-cell stage; animal caps were explanted at stage 8 and
incubated in cycloheximide (10 ug/ml), as indicated, until late gastrula stages. Cycloheximide
alone is sufficient to increase expression of brachyury and goosecoid (Kurth et al., 2005; Tadano
et al., 1993).
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3.3 Discussion
T-box transcription factors mediate cell specification and patterning in the early vertebrate embryo.
Our results point to a central role for Tbx2-Smad interactions in the inhibition of both ventral and
mesodermal fates. The inability of Tbx2S1T to consistently repress ventral markers, while
effectively blocking mesoderm induction, indicates that different domains of Tbx2 may be
necessary to repress the Activin/Nodal and BMP/GDF pathways. We find that the Tbx2 Spacer 1
and T-box domains are sufficient for interaction with R-Smads. Because the T-box is necessary
for Tbx2 activity, it was not possible to inhibit R-Smad association without eliminating a domain
presumably required for DNA binding. A point mutation in the T-box of Tbx2 demonstrates that
Tbx2 associates with R-Smads independently of DNA binding. Misexpression of the Tbx2 DNAbinding mutant does not repress ventral or mesodermal markers, indicating that repression of
ventral and mesodermal markers requires DNA binding. We have also identified several direct
targets of Tbx2.
In a previous study, we demonstrated that Tbx2 dorsalizes ectoderm and is necessary and sufficient
for the suppression of mesoderm and endoderm in the animal pole of the gastrula stage X. laevis
embryo (Teegala et al., 2018). Like Tbx2, several other repressors of mesodermal and ventral gene
expression in the ectoderm function by inhibiting both the Activin/Nodal and BMP/GDF branches
of the TGFβ signaling pathway (Bell et al., 2003; Casellas and Brivanlou, 1998; Xu et al., 2012).
In the TGFβ signaling pathway, R-Smad proteins are present in the cytoplasm until they are
phosphorylated following ligand receptor binding, and translocate into the nucleus (Macías-Silva
et al., 1996). As knockdown of tbx2 in animal cap explants stimulates expression of mesodermal
markers, it is possible that Tbx2 prevents low levels of phosphorylated R-Smads present in the
nucleus from having an appreciable effect on mesendodermal and/or ventral gene expression.
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Various T-box transcription factors such as Eomesodermin, Brachyury, and Tbx20 have been
shown to associate with either Smad1 or Smad2 and have been shown to function in either the
BMP/GDF or Activin/Nodal pathways (Messenger et al., 2005; Picozzi et al., 2009; Singh et al.,
2009). Here, we describe a T-box protein that associates with both classes of R-Smad and that
represses both branches of the TGFβ signaling network. The association between Brachyury and
Smad1 requires BMP signaling and is necessary for the activation of Vent2.2 (Xom), a repressor
of goosecoid (Messenger et al., 2005). If the association between Brachyury and Smad1 is
attenuated, Brachyury activates goosecoid, and only high levels of both Brachyury and the BMP
antagonist Noggin can activate goosecoid (Messenger et al., 2005). These results suggest that
Brachyury activity is dependent on the level of BMP signaling and, subsequently, the levels of
Smad1 in the nucleus. An analogous scenario possibly occurs in the presumptive ectoderm,
whereby ventral Tbx2 activity is suppressed by high levels of nuclear Smad1.

The domains of Smad1 and Smad2 necessary for Tbx2 association remain unknown. Brachyury,
Eomesodermin, and Tbx20 have all been shown to physically associate with R-Smads (Messenger
et al., 2005; Picozzi et al., 2009; Singh et al., 2009). To our knowledge, the R-Smad domain(s)
necessary for the association with Eomesodermin and Tbx20 are not defined; Brachyury associates
via its N-terminus with Smad1 via the Smad1 C-terminus (Messenger et al., 2005). Sequence
analysis does not show any appreciable alignment between the N-terminus of Brachyury and any
region of Tbx2. Additionally, unlike Tbx2, Brachyury does not associate with Smad2 (Messenger
et al., 2005).
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T-box proteins have been shown to play an important role in a neuromesodermal bimodal “switch”
to either promote mesodermal or neural gene expression at the expense of the other (Gentsch et
al., 2013). The current study and previous data from our group show that Tbx2 promotes
neuralization at the expense of a mesendodermal fate (Teegala et al., 2018). Our data suggest that
Tbx2 may not inhibit R-Smad function directly; it is also possible that the Tbx2-Smad association
is necessary for Tbx2 repressor activity in the context of germ layer differentiation. Many
transcription factors that are responsible for controlling cell fate commitment in developing
embryos also regulate development of pluripotent stem cells (Pei, 2009; Takahashi and Yamanaka,
2006). Identifying transcription factors necessary for germ layer differentiation, including Tbx2,
and defining their mechanisms of action thus has far-reaching implications in multiple areas of
biology.

3.4 Conclusion
During gastrulation, T-box transcription factors play important roles in cell fate specification
(Kofron et al., 1999; Smith et al., 1991; Teegala et al., 2018; Xanthos et al., 2001). For the first
time, we show physical association between Tbx2 and intracellular mediators of both the
BMP/GDF and Activin/Nodal signaling pathways. Protein-protein interaction assays indicate that
the Tbx2 T-box is sufficient for association with R-Smads; furthermore, structure/function analysis
identify a novel repressor domain in Tbx2 located in either the first spacer or the T-box. Inhibition
of DNA binding by Tbx2 blocks its ability to inhibit ventral and mesodermal fate. Our studies
suggest a model in which Tbx2 physically associates with Smad1 or Smad2, represses transcription
of BMP/GDF or Activin/Nodal targets, and thus inhibits expression of ventral and mesodermal
genes, respectively.
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4 Chapter IV: Epigenetic mechanism of Tbx2 repression
4.1 Background
T-box proteins play an important role in the specification of cell fate. For example, Brachyury and
Eomesodermin, T-box transcription factors present in the mesoderm, function as activators to
specify a mesodermal cell fate (Picozzi et al., 2009; Smith et al., 1991). Recent work has shown
that during gastrulation, T-box proteins also suppress inappropriate gene expression; Tbx2, a Tbox transcription factor, functions as a repressor in the ectoderm to suppress mesodermal,
endodermal, and ventral gene expression (Reich et al., 2020; Teegala et al., 2018).

During early development, ventral and mesendodermal gene expression is regulated largely by the
BMP/GDF and Activin/Nodal branches of the TGFβ signaling pathway, respectively ((Howell and
Hill, 1997; Schmidt et al., 1995; Wilson and Hemmati-Brivanlou, 1995). Previous studies have
shown that mesodermal-specific T-box transcriptional activators physically associate with
intracellular mediators of the TGFβ signaling pathway; in some studies, loss of this association
results in aberrant T-box activity (Messenger et al., 2005; Picozzi et al., 2009). Recently, our lab
showed that Tbx2 represses both the BMP/GDF and Activin/Nodal branches of the TGFβ signaling
pathway, and physically associates with intracellular mediators of each branch (Reich et al., 2020;
Teegala et al., 2018) (Chapter 3). However, the process through which Tbx2 functions to repress
gene expression remains elusive. In the study described here, we attempt to identify the
mechanisms through which Tbx2 mediates germ layer suppression. Immunoprecipitation and
subsequent mass spectrometry, co-immunoprecipitation, and western blot analysis experiments
suggest an epigenetic mechanism through which Tbx2 may repress gene expression.
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4.2 Results
4.2.1 Tbx2 physically associates with xH2A, xH2A.X, and xH2A.Z
During gastrulation, Tbx2 functions downstream of multiple signaling pathways to repress
inappropriate gene expression. Previous data has shown that Tbx2 represses Activin, FGF, and
BMP- mediated gene expression (Figure 4.1) (Reich et al., 2020; Teegala et al., 2018).

Protein-protein interaction assays, described above (Chapter 3), show that Tbx2 physically
associates with intracellular mediators of the Activin/Nodal and BMP/GDF signaling pathways.
However, these interactions are likely insufficient to explain the mechanism through which Tbx2
represses signaling pathways independent from intracellular mediators of TFG signaling.
Therefore, we sought to identify additional Tbx2-binding partners in order to further define the
mechanisms through which Tbx2 inhibits divergent signaling networks.
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Figure 4-1 Tbx2 represses V-RAS-mediated mesoderm expression.
A) RT-PCR analysis of animal cap explants injected with tbx2 and v-ras. Embryos were injected
with 1ng tbx2, 40 pg v-ras, or 1ng tbx2 and 40 pg of v-ras at the two-cell stage; animal caps were
explanted at stage 8.5 and incubated until late gastrula stages.

To identify additional binding partners of Tbx2, we performed immunoprecipitations and
subsequent mass spectrometry (IP-mass spec). As we have not been able to obtain an antibody that
recognizes native Tbx2, we used a Myc-Tbx2 epitope-tagged vector (Myc-Tbx2), and injected
myc-tbx2 synthetic RNA into early cleavage stage embryos. Embryos were collected at midgastrulation and immunoprecipitated with an anti-Myc or control Mouse IgG1 antibody. The
resulting immunoprecipitates were subjected to mass spectrometry. Histone 2A (H2A), a major
component of chromatin structure, immunoprecipitated in the samples incubated with the antiMyc antibody. To confirm this association, we generated X. laevis Flag- and Ha-tagged H2A
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constructs (FxH2A and HAxH2A). Immunoprecipitation and western blot analysis confirmed the

Tbx2 physically associates with xH2A

physical association between Histone 2A and Tbx2 in X. laevis embryos (Figure 4.2 A,B).
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Figure 4-2 Tbx2 physically associates with xH2A.
A) 1 ng myc-tbx2 and 1 ng of ha-xH2A RNA were injected at early cleavage stages. Pull-down of
Myc-Tbx2 from injected embryos leads to co-immunoprecipitation of exogenous xH2A. Normal
Mouse IgG1 antibodies were used in a parallel study as a negative control. B) The reciprocal
experiment of A. 1 ng myc-tbx2 and 1 ng of flag-xH2A RNA were injected at early cleavage stages.
Pull-down of Flag-xH2A from injected embryos leads to co-immunoprecipitation of exogenous
Tbx2. Normal Rabbit IgG antibodies were used in a parallel study as a negative control.
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Histone 2A is a component of the histone octamer nucleosome core around which an average of
147 DNA base pairs are wrapped (Wood et al., 2005). The histone octamer plays a major role in
regulating the accessibility of transcription factor binding sites (Walter et al., 1995). Posttranslational modifications to the structural “tails” of various Histones regulate the DNA-octamer
association; modifications can sterically hinder or expose access to DNA cis-regulatory elements
(Bowman and Poirier, 2015). In addition to the predominant form, several Histone 2A variants
have been characterized (Bönisch and Hake, 2012). The most common variants of Histone 2A are
Histone 2A.X (H2A.X) and Histone 2A.Z (H2A.Z). As both of these variants are expressed
spatially and temporally in similar patterns to Tbx2, we examined whether Tbx2 can associate with
one or both of these variants (Lee et al., 2010; Session et al., 2016; Shin et al., 2005). To determine
whether Tbx2 can associate with these H2A variants, we generated Flag- and HA-tagged Histone
2A variant constructs - H2A.X (FxH2A.X/HAxH2A.X) and H2A.Z (FxH2A.Z/HAxH2A.Z) . To
test if Tbx2 associates with xH2A.X, 1 ng of myc-Tbx2 was injected with either 1ng of fxH2A.X
or 1ng of HA-xH2A.X into early cleavage stage embryos. Immunoprecipitation and western blot
analysis demonstrate that Tbx2 physically associates with xH2A.X (Figure 4.3 A,B). Using
immunoprecipitation and western blot analysis, the association between Tbx2 and xH2A.Z was
confirmed, as well. (Figure 4.2 A, B; Figure 4.3 A, C). Thus, Tbx2 associates with xH2A, xH2A.X
and xH2A.Z.
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Figure 4-3 Tbx2 physically associates Histone 2A variants.
A) Tbx2 physically associates with xH2A.X and xH2A.Z. 1ng of myc-tbx2 and 1ng of haxH2A.X or ha-xH2A.Z were injected into early cleavage embryos. Pull-down of Myc-Tbx2 from
injected embryos leads to co-immunoprecipitation of exogenous xH2A.X (lane 2) and xH2A.Z
(lane 4). Normal Mouse IgG1 antibodies were used in a parallel study as a negative control. B)
and C) Reciprocal experiments of Figure A. 1 ng myc-tbx2 and 1 ng of flag-xH2A.X (B) or 1 ng
of flag-xH2A.Z (C) were injected at early cleavage stages. Pull-down of Flag-xH2A.X or FlagxH2A.Z from injected embryos leads to co-immunoprecipitation of exogenous Tbx2. Normal
Rabbit IgG antibodies were used in a parallel study as a negative control.
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4.2.2 xH2A associates with R-Smads
Because Tbx2 associates with both Smad1 and Smad2, we wondered whether Smad1 and Smad2
also physically associate with xH2A (Reich et al., 2020). To address this possibility, 1ng of HAxH2A and 1ng of flag-Smad2 were injected into early cleavage stage embryos. Embryos were
cultured until late gastrulation. Pulldown with an anti-Flag antibody and subsequent Western
blotting shows that HA-xH2A physically associates with the Activin/Nodal--pathway specific RSmad, Smad2 (Figure 4.4 A, lanes 1 and 2). Like Smad2, the BMP specific R-Smad, Smad1,

xH2A physically associates with R-Smads

associates with HA-xH2A (Figure 4.4B).
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Figure 4-4 xH2A physically associates with R-Smads.
A). 1ng of myc-Smad2 and 1ng of flag-xH2A (lanes 1 and 2), or 1ng of myc-Smad2, 1ng of flagxH2A, and 1ng of tbx2 (lanes 3 and 4) were injected into early cleavage embryos. Pull-down of
Flag-xH2A from injected embryos leads to co-immunoprecipitation of exogenous Smad2 (lane
2). Overexpression of tbx2 does not inhibit the association between xH2A and Smad2 (compare
lanes 2 and 4) . Normal Rabbit IgG antibodies were used in a parallel study as a negative control.
B) Smad1 physically associates with xH2A. 1 ng of flag-xH2A or was injected at early cleavage
stages. Pull-down of endogenous Smad1 from injected embryos leads to co-immunoprecipitation
of exogenous xH2A. Normal Rabbit IgG antibodies were used in a parallel study as a negative
control.
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Because previous data show that Tbx2 physically associates with R-Smads, and here we show that
R-Smads associate with xH2A, we wondered whether overexpression of Tbx2 inhibits the
association between R-Smads and xH2A. To test this, early cleavage stage embryos were injected
with 1ng of myc-Smad2, 1ng of fxH2A, and 2ng of tbx2. Immunoprecipitation and western blot
analysis show no difference in the level of association between Smad2 and FxH2A when Tbx2 is
overexpressed in the animal pole compared with embryos injected with only myc-Smad2 and
fxH2A. (Figure 4.4 A, compare lanes 2 and 4).

4.2.3 The first spacer and T-box are sufficient for Tbx2/xH2A association
To determine if the Tbx2/Histone 2A association is necessary for Tbx2-mediated germ layer
suppression, we attempted to separate the physical association between Tbx2 and Histone 2A and
the repressor activity of Tbx2. Tbx2S1T is the smallest constructed deletion construct that represses
mesodermal markers. If Histone 2A does not associate with this construct, it would suggest that a
physical association between Histone 2A and Tbx2 is not necessary for Tbx2S1T-mediated
mesodermal repression. To test this, we co-injected flag-hH2A and myc-Tbx2S1T into early
cleavage X. laevis embryos. Immunoprecipitation and Western blot analysis show a physical
association between Histone 2A and Tbx2S1T (Figure 4.5A).
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Figure 4-5 Tbx2S1T and Tbx2R-A associate with hH2A.
A) Tbx2R-A physically associates with xH2A. 1 ng myc-tbx2R-A and 1 ng of flag-xH2A RNA
was injected into the animal pole at early cleavage stages. Pull-down of Flag-xH2A from
injected embryos leads to co-immunoprecipitation of exogenous Myc-Tbx2R-A. Normal Rabbit
antibodies were used in a parallel study as a negative control. B) Tbx2S1T physically associates
with xH2A. 1 ng myc-tbx2S1T and 1 ng of flag-xH2A RNA were injected into the animal pole at
early cleavage stages. Pull-down of Flag-xH2A from injected embryos co-immunoprecipitates
exogenous Myc-Tbx2S1T. Normal Rabbit antibodies were used in a parallel study as a negative
control
4.2.4 A Tbx2 DNA-binding mutant physically associates with xH2A
T-box proteins are well-characterized as transcription factors; we thus wondered if Tbx2 DNA
binding is necessary for Tbx2-xH2A association. To determine this, we used the Tbx2 DNAbinding mutant mentioned previously in protein-protein interaction experiments. During early
cleavage stages, 1ng of myc-Tbx2R-A and 1ng of flag-hH2A were injected into the animal pole.
Embryos were harvested at mid-to-late gastrula stages. Immunoprecipitation and Western blot
analysis demonstrate that Histone 2A physically associates with Myc-Tbx2R-A (Figure 4.5 B).
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4.3 Discussion

The eukaryotic genome is organized into chromatin which allows it to fit into the nucleus. This
chromatin structure is composed of nucleosomes which consist of DNA wrapped around histone
octamers. These octamers are composed of two Histone 2As, two Histone 2Bs, 2 Histone 3s, and
2 Histone 4s (Bönisch and Hake, 2012). Histone modifications manipulate the chromatin structure
and can make DNA more or less accessible during a number of important of biological processes
such as DNA replication, DNA repair, transcriptional regulation, and genome stability (Bhaumik
et al., 2007). Histone 2A variants are variants of the canonical Histone 2A and contribute to
chromatin complexity. Histone 2A can be replaced with a Histone 2A variant, which has a
profound effect on the biological outcome. Amino acid sequences of the Histone 2A variants are
most divergent near their C-termini, where most Histone modifications occur (Bönisch and Hake,
2012). There are many identified Histone 2A variants. The two variants considered “universal,”
found in almost every organism examined, are H2A.X and H2A.Z (Bönisch and Hake, 2012).
Here, we show that Tbx2 and R-Smads physically associates with xH2A, and that Tbx2 also
associates with the universal H2A variants, H2A.X and H2A.Z.

The domain of Tbx2 necessary for the Tbx2-H2A association is located in the first spacer and/or
T-box of Tbx2. This construct designed to include these regions, Tbx2S1T, contains a repressor
domain; overexpression of tbx2S1T is sufficient to repress mesodermal but not ventral gene
expression (Figure 3.5 A) (Reich et al., 2020). This suggests that the association alone between
Tbx2 and H2A is not sufficient for repression of ventral gene expression. Additionally, the Tbx2
DNA-binding mutant, Tbx2R-A, binds both Smad1 and Smad2, but does not repress either
mesodermal or ventral gene expression (Reich et al., 2020). Here we show that Tbx2R-A
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associates with H2A, again suggesting that the Tbx2-H2A protein interaction is not sufficient for
Tbx2 repressor activity.

As xH2A is a component of the Histone octamer, it is possible that Tbx2 associates indirectly with
xH2A and directly with either a different Histone, or a Histone/chromatin-modifying protein.
Many previously identified Histone-modifying proteins play a crucial role in germ layer
patterning. For example, the Polycomb Repressor Complex 2 (PRC2) trimethylates H3K27 to
silence gene expression and maintain cell fate identity. (Laugesen et al., 2016). Previous studies
show that Tbx3, a T-box protein that can function as an activator of endodermal gene expression,
physically associates with the histone demethyltransferase, JMJD3 (Kartikasari et al., 2013).
During endodermal differentiation, Tbx3 recruits JMJD3 to the promoter region where JMJD3
demethylates H3K27 to activate gene expression (Kartikasari et al., 2013). Planned studies in our
lab include protein-protein association assays to determine whether Tbx2 physically associates
with JMJD3 and inhibits its ability to function as a demethyltransferase.

4.4 Conclusion
Many T-box transcription factors have been shown to play important roles in pluripotency and cell
fate determination during gastrulation. Our previous studies suggest a model in which Tbx2
physically associates with Smad1 or Smad2, represses transcription of BMP/GDF or
Activin/Nodal targets, and thus inhibits expression of ventral and mesodermal genes, respectively
(Reich et al., 2020). The studies described in this chapter suggest that Tbx2 uses an epigenetic
mechanism to repress gene expression. We show that Tbx2 can physically associate with xH2A,
xH2A.X, and xH2A.Z. The physical association between Tbx2 and R-Smads, R-Smads and xH2A,
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and Tbx2 and xH2A, suggests a model in which Tbx2 is a component in a complex that includes
R-Smads and xH2A. Future work will explore additional chromatin modifying binding partners of
Tbx2 in an attempt to further characterize the function of Tbx2.
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5 Chapter V: Conclusion and future directions
During vertebrate development, the formation and patterning of the three germ layers is a rapid
and tightly regulated process; studies in the frog X. laevis have been essential for our
understanding of these processes. An initiating step in development of the germ layers occurs when
VegT, a maternally supplied transcription factor, directly initiates an endoderm-specific gene
expression program among cells located in the vegetal pole (Horb and Thomsen, 1997). VegT also
activates nodal and nodal-related gene expression; these transcripts encode proteins that induce
cells in the region adjacent to the vegetal pole, in the so-called marginal zone, to differentiate into
mesoderm (Kofron et al., 1999; Xanthos et al., 2001). In this VegT-centric model of germ layer
formation, differentiation in the animal pole is the consequence of an absence of both extracellular
signaling and germ layer-specific transcriptional activation -- VegT is not expressed in this region,
and it is far from the source of Nodal signaling; thus, neither endodermal nor mesodermal
differentiation ensues, and ectoderm forms in the animal pole “by default” (Heasman, 2006;
Hemmati-Brivanlou and Melton, 1994).

Recently, however, it has become clear that the suppression of inappropriate cell fate also plays a
critical role in germ layer determination in the vertebrate embryo (Reich and Weinstein, 2019).
The BMP branch of the TGFβ signaling pathway regulates ventral/dorsal patterning in the
ectoderm during gastrulation; high levels of BMP signaling are present on the ventral side of the
ectoderm, while low levels of BMP signaling are present in the dorsal side of the ectoderm
(Simeoni and Gurdon, 2007; Weinstein and Hemmati-Brivanlou, 1997). The absence of TGFβ
signaling in the dorsal ectoderm gives rise to what is considered the “default” state of the ectodermneural tissue (Weinstein and Hemmati-Brivanlou, 1997). Recent studies have shown that not only
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is the absence of induction necessary for the default neural fate to differentiate, but several proteins
present in the ectoderm are required for the repression of mesoderm/endodermal gene expression
in the ectoderm during gastrulation (Reich and Weinstein, 2019). This thesis describes one such
factor: Tbx2, a T-box transcription factor present in the animal pole during gastrulation, Tbx2, has
been shown to be necessary for endodermal and mesodermal gene repression in the ectoderm.

The work presented in this thesis suggests a model that begins to elucidate the mechanisms through
which Tbx2 functions to repress gene expression. Embryological and protein-protein assays show
that Tbx2 physically associates with both Smad1 and Smad2, and represses Smad1- and Smad2mediated gene expression; namely ventral- and mesodermal-specific genes (Figure 5.1 B). We
determine here that the Tbx2 deletion construct Tbx2S1T is sufficient to associate with R-Smads,
and that this construct contains a previously unidentified repressor domain. Overexpression of
tbx2S1T is sufficient to repress mesodermal genes and insufficient to repress ventral markers,
suggesting that the mechanism through which Tbx2 represses the Activin/Nodal pathway may
differ from the mechanism though which Tbx2 represses the BMP/GDF branch of the TGFβ
signaling pathway. Additionally, we show that a Tbx2 DNA-binding mutant associates with RSmads, suggesting that Tbx2-R-Smad association is independent from the ability of Tbx2 to bind
DNA.
The Tbx2-R-Smad association identified in this thesis has not been shown to be necessary for
Tbx2-mediated transcriptional repression. In order to determine if this association is necessary for
Tbx2 activity, we will attempt to separate the R-Smad association from DNA-binding activity. In
order to accomplish this, several successively smaller deletion constructs of the Tbx2 T-box will
be constructed and assayed for R-Smad association and DNA-binding activity. If removal of the
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amino acid sequence required for R-Smad association abolishes repressor activity while DNAbinding activity remains intact, this would suggest that Tbx2 repressor activity requires R-Smad
association.
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A

B

Figure 5-1 Model of protein-protein interactions.
A) Simplified model of the Activin/Nodal and BMP/GDF branches of the TGFβ signaling
pathway. B) Simplified model of role of Tbx2 in suppression of TGFβ signaling.
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Because Tbx2 represses genes activated by the FGF, BMP/GDF, and Activin/Nodal pathways, we
attempted to identify a chromatin-modifying binding partners that might function downstream of
multiple pathways. IP-Mass spectrometry identified Histone 2A as a binding partner of Tbx2. Coimmunoprecipitation experiments suggest a model in which Tbx2, H2A, and R-Smads form a
complex. Future experiments will continue to identify binding partners of Tbx2 in order to fully
characterize the mechanism through which Tbx2 represses inappropriate gene expression.

The protein-protein interaction assays described above demonstrate that Tbx2 physically
associates with Histone 2A. It is well established that histone modifications play an important role
in gene regulation. For example, trimethylation of Histone 3 lysine 27 silences gene expression
(Wiles and Selker, 2017). A common modification of Histone 2A is the ubiquitination of Lysine
119 (H2AK119u1) on the histone tail (Wang et al., 2004). Ring1 and Ring1B are E3 ubiquitin
ligases (Zhou et al., 2008). These Ring family ubiquitin ligases are the catalytic components of the
Polycomb Repressive Complex 1 that mediate deposition of ubiquitin on Histone 2A. Monoubiquitination is most commonly associated with transcriptional repression. Histone 2A monoubiquitination represses transcription by preventing the release of RNA polymerase, stunting
elongation (Dellino et al., 2004). In X. laevis, knockdown of USP-12, a Histone 2A deubiquitinase,
in whole embryos during early development leads to a reduction of mesoderm-specific gene
expression (Joo et al., 2011). This suggests that Ring1-mediated monoubiquitination of H2AK119
may repress the transcription of mesodermal genes. Further experiments are needed to determine
whether Ring1 functions downstream of Tbx2 to repress mesodermal gene expression via Histone
2A ubiquitination.
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